Stensolo en es it fr

Stensolo Brand names, Stensolo Analogs

Stensolo Brand Names Mixture

  • No information avaliable

Stensolo Chemical_Formula


Stensolo RX_link

No information avaliable

Stensolo fda sheet

Stensolo msds (material safety sheet)

Stensolo Synthesis Reference

No information avaliable

Stensolo Molecular Weight

309.469 g/mol

Stensolo Melting Point

< 25 oC

Stensolo H2O Solubility

Soluble as HCl salt

Stensolo State


Stensolo LogP


Stensolo Dosage Forms

Tablets (oral, 1 mg)

Stensolo Indication

Used for the symptomatic treatment of parkinsonism.

Stensolo Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Stensolo Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Stensolo side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Stensolo Patient Information

Stensolo Organisms Affected

Humans and other mammals